StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) opens down 12% as flu data called 'undifferentiated'
December 10, 2021 9:32 AM
Moderna (NASDAQ: MRNA) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Trader Talk
Next Articles
Moderna (MRNA) and Australia Collaborate to Bring mRNA Manufacturing to Australia
December 14, 2021 5:50 AM
Moderna's (MRNA) COVID-19 Vaccine Manufactured in Korea by Samsung Granted Marketing Authorization from Ministry of Food and Drug Safety of Korea
December 14, 2021 5:46 AM
Moderna (MRNA) Continues to Grind off Lows, Remains Down 5.5%
December 10, 2021 12:14 PM
